Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT07396766

Recruiting

Dissemination of BREASTChoice AIM1-B (BREASTChoice)

Breast Cancer | Breast Neoplasms
NCT07385365

Not yet recruiting

A Study of Postoperative Regional Nodal Radiotherapy in Intermediate-risk Breast Cancer

Breast Cancer
NCT07382687

Not yet recruiting

Famitinib Combined With SHR-A1811, Versus SHR-A1811 for CDK4/6 Inhibitors-resistent Advanced HR+/HER2- Breast Cancer With SNF4 Subtype

Breast Cancer
NCT07367269

Recruiting

Effect of Mandala Coloring on Anxiety, Distress, and Comfort in Breast Cancer Patients Receiving Outpatient Chemotherapy

Breast Cancer
NCT07362914

Recruiting

Corticosteroids for Doxorubicin Liposome-Induced Hand-Foot-Skin Reactions (CHORD)

Breast Cancer
NCT07357298

Recruiting

Phase III Trial of Brain MRI Surveillance in Stage IV Breast Cancer

Breast Cancer
NCT07354490

Not yet recruiting

Accuracy of Sono-mammographic Features in Molecular Classification of Breast Cancer

Breast Cancer
NCT07349069

Recruiting

A Phase III Trial Comparing HRS-8080 With Standard Endocrine Therapy in Patients With Intermediate or High Risk Early Breast Cancer

Breast Cancer
NCT07335081

Recruiting

ctDNA in HER2+ EBC Neoadjuvant Treatment

Breast Cancer
NCT07330544

Recruiting

A Phase II Clinical Study Evaluating Entinostat With or Without Anlotinib + Fulvestrant for the Treatment of Hormone Receptor (HR) -Positive, Human Epidermal Growth Factor Receptor-2 (HER-2) -Negative Advanced Breast Cancer That Relapsed or Progressed After Endocrine Therapy

Breast Cancer
NCT07327970

Recruiting

Prospective Validation of Ataraxis AI Test for Predicting Treatment Response in Neoadjuvant Breast Cancer (ATARAXIS NEOP)

Breast Cancer
NCT07319195

Recruiting

Window Study of Intratumoral Mitazalimab in Breast Cancer (WINIT-BC) (WINIT-BC)

Breast Cancer
NCT07311122

Not yet recruiting

Endocrine Therapy Base on 21-gene RS (CUSTOM)

Breast Cancer
NCT07308717

Recruiting

Gabapentin And Breast Surgery Decision Architecture Randomization Trial (GABS-DART) Protocol

Breast Cancer
NCT07300215

Not yet recruiting

An Exploratory Study on Individualized Neoadjuvant Treatment Regimens for Early HR+/HER2+ Breast Cancer

Breast Cancer
NCT07275203

Not yet recruiting

Concordance of the Biology of Primary Breast Carcinoma and the Biology of Recurrence .

Breast Carcinoma
NCT07258108

Recruiting

Sac-TMT Plus KL-A167 in PD-L1+, HR+/HER2- Metastatic Breast Cancer After CDK4/6 Inhibitors

Breast Cancer
NCT07253168

Not yet recruiting

Tumor Integrating Gut Microbiota in bREast Cancer (TIGER-BC)

Breast Cancer
NCT07246317

Not yet recruiting

Evaluation of Neoadjuvant Therapy With Trastuzumab, Pertuzumab, Docetaxel, and QL1706 in Early or Locally Advanced HER2+ Breast Cancer

Breast Cancer
NCT07237256

Recruiting

Chemotherapy De-escalation in HR +, HER2-, Intermediate-risk Early Breast Cancer Treated With Adjuvant Ribociclib (NoLEEta)

Breast Cancer
NCT07229378

Not yet recruiting

Respiratory Muscle Strength Training to Prevent Respiratory Muscle Weakness in Adults Newly Diagnosed With Breast Cancer

Breast Cancer
NCT07209436

Recruiting

Impact of Pectoral Versus Paravertebral Blocks on Pain and Physical Well-Being in Implant-Based Breast Reconstruction

Breast Reconstruction
NCT07180056

Recruiting

Adjuvant CDK4/6 Inhibitor Use in HR+/HER2- Breast Cancer

Breast Cancer
NCT07162298

Recruiting

Dragon Boat Race Versus Family Unsupervised Training to Improve the Physical Function and Quality of Life in Breast Cancer Patients

Breast Cancer
NCT07151911

Recruiting

Real wOrld studY in the Adjuvant Setting for High Risk earLy Breast Cancer Patients (ROYAL)

Breast Cancer
NCT07142096

Recruiting

WinQ : a Window of Opportunity Study With MitoQ in Breast Cancer (WinQ)

Breast Cancer
NCT07590505

Completed

Ultrahypofractionated Versus Normofractionated Sequential Boost After Whole-breast Radiation Therapy in Patients Treated With Breast-conserving Surgery for Breast Cancer (ULTIMO)

Breast Cancer
NCT07519668

Completed

Retrospective Evaluation of Ultrasound-assisted Tumor Surgery in Breast-conserving Therapy (MAC004)

Breast Cancer
NCT07307911

Completed

Coenzyme Q10 for Neuroprotection in Paclitaxel-Induced Neuropathy (Co-Pa-N)

Breast Cancer
NCT07474246

Completed

A Innovative Web-based Dance Movement Therapy

Breast Cancer
NCT07441330

Terminated

Evaluation of Data Obtained From Three Common Imaging Techniques: Positron Emission Tomography (PET-CT), Breast Ultrasound, and Magnetic Resonance Imaging (MRI) After Neoadjuvant Chemotherapy in Patients With Breast Cancer

Breast Cancer
NCT07407244

Active, not recruiting

Immune Tumor Stroma Factors and Pathologic Complete Response After Neoadjuvant Chemotherapy in Early Breast Cancer (AKRA)

Breast Cancer
NCT07229560

Completed

A Trial of Itraconazole Effect on HRS-8080 Pharmacokinetics in Healthy Participants

Breast Cancer
NCT07316439

Active, not recruiting

Comparison Between ER Loss and Triple-Negative Breast Cancer Guided by 18F-FES PET/CT in Metastatic Breast Cancer

Breast Cancer
NCT07287111

Completed

Effectiveness of CadAI-B Dx for Decision Support in Breast Ultrasound

Breast Cancer | Breast Neoplasms
NCT07274800

Completed

Adjuvant Ultra-Hypofractionated vs Hypofractionated Radiotherapy for Early Breast Cancer (UHF vs HF-EBC)

Breast Cancer
NCT07223476

Completed

Treatment Landscape and Real-World Dosing Patterns With CDK4/6 Inhibitors for Breast Cancer in Portugal (PORTRAIT)

Breast Cancer
NCT01160510

Completed

Genetics of Mammographic Appearances and Patterns (The GenMap Study)

Benign Breast Disease
NCT07581834

Recruiting

Efficacy and Safety of Dalpiciclib Combined With Endocrine Adjuvant Therapy for Early HR +/HER2- Breast Cancer: a Multicenter, Prospective Clinical Study

Breast Neoplasms | Breast Diseases | Endocrine Breast Diseases | HR+/HER2- Breast Cancer | CDK4/6 Inhibitor | Dalpiciclib
NCT06937281

Not yet recruiting

SABR PRIMER - Evaluating Stereotactic Ablative Radiotherapy for Primary and Regional Breast Tumors (SABR PRIMER)

Breast Cancer | Metastases
NCT06923527

Recruiting

Circulating Tumor DNA

ER+ Breast Cancer
NCT06832904

Recruiting

Neoadjuvant Chemotherapy Plus Pyrotinib and Trastuzumab for HER2-positive Breast Cancer (NEOTORCH-BREAST05)

HER2-positive Breast Cancer | Neoadjuvant Therapy | Pyrotinib
NCT06849947

Not yet recruiting

Fulvestrant With Ribociclib Versus Physician's Choice Treatments Recurred After Completion of Adjuvant Cyclin-Dependent Kinase 4/6 Inhibitors in HR+, HER2- Metastatic Breast Cancer

Breast Cancer Metastatic
NCT06800989

Recruiting

To Assess the Contribution of Sophrology Assisted by an Ambulatory Device on the Anxiety of Patients Undergoing Chemotherapy for the Treatment of Localized Breast Cancer (DOMI-SOPHRO)

Breast Cancer Female
NCT06767462

Recruiting

An Ophthalmic Safety Study in Patients With Breast Cancer

Ophthalmic Safety in Patients With Breast Cancer
NCT06544577

Recruiting

Safety of Elacestrant in ER+/HER2- and ESR1 Mutations MBC

Advanced Breast Cancer | Safety | ESR1 Gene Mutation
NCT06468566

Recruiting

Identification of Benign and Malignant Breast Nodules Using Ultrasound-modulated Optical Tomography: A Multicenter Study

Breast Cancer Female
NCT06458413

Recruiting

Utidelone Capsule Plus Capecitabine (CAP) for Metastatic Breast Cancer

Breast Cancer Recurrent
NCT06435104

Not yet recruiting

Aromatherapy in the Treatment of Early Breast Cancer

Early Breast Cancer
NCT06027983

Not yet recruiting

Chimeric Receptor T Cells With Trastuzumab in HER2+ Advanced Breast Cancer and Other Solid Tumors

Other Solid Tumors | HER2+ Advanced Breast Cancer

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations